Once Daily Immunosuppression Regimen

PHASE4TerminatedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

November 10, 2023

Study Completion Date

November 10, 2023

Conditions
Kidney Transplant; Complications
Interventions
DRUG

Once daily immunosuppression regimen

Intervention focuses on the type of regimen, in this case the intervention arm will receive a once daily regimen for immunosuppression compared to the twice daily regimen.

DRUG

Twice daily immunosuppression regimen

This is the arm which we are designating the standard, which will be the comparison to the active drug arm.

Trial Locations (1)

63110

Washington University, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

Washington University School of Medicine

OTHER